Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Friedman, HS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 221 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gururangan, S; Cokgor, I; Rich, JN; Edwards, S; Affronti, ML; Quinn, JA; Herndon, JE; Provenzale, JM; McLendon, RE; Tourt-Uhlig, S; Sampson, JH; Stafford-Fox, V; Zaknoen, S; Early, M; Friedman, AH; Friedman, HS
      Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas

      NEURO-ONCOLOGY
    2. Friedman, HS; Keir, ST; Houghton, PJ; Lawless, AA; Bigner, DD; Waters, SJ
      Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    3. Cavazos, CM; Keir, ST; Yoshinari, T; Bigner, DD; Friedman, HS
      Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione] against pediatric and adult central nervous system tumor xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    4. Struck, RF; Tiwari, A; Friedman, HS; Keir, S; Morgan, LR; Waud, WR
      Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolite of penclomedine

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Keir, ST; Hausheer, F; Lawless, AA; Bigner, DD; Friedman, HS
      Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    6. Ewesuedo, RB; Wilson, LR; Friedman, HS; Moschel, RC; Dolan, ME
      Inactivation of O-6-alkylguanine-DNA alkyltransferase by 8-substituted O-6-benzylguanine analogs in mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Cokgor, I; Akabani, G; Friedman, HS; Friedman, AH; Zalutsky, MR; Zehngebot, LM; Provenzale, JM; Guy, CD; Wikstrand, CJ; Bigner, DD
      Long term response in a patient with neoplastic meningitis secondary to melanoma treated with I-131-radiolabeled antichondroitin proteoglycan sulfateMel-14 F(ab ')(2) - A case study

      CANCER
    8. Friedman, HS
      Serum homocysteine and stroke in atrial fibrillation

      ANNALS OF INTERNAL MEDICINE
    9. Friedman, HS
      Paradoxes of nonverbal detection, expression, and responding: Points to ponder

      INTERPERSONAL SENSITIVITY: THEORY AND MEASUREMENT
    10. Mahoney, DH; Cohen, ME; Friedman, HS; Kepner, JL; Gemer, L; Langston, JW; James, HE; Duffner, PK; Kun, LE
      Carboplatin is effective therapy for young children with progressive opticpathway tumors: A Pediatric Oncology Group phase II study

      NEURO-ONCOLOGY
    11. Wiltshire, RN; Rasheed, BKA; Friedman, HS; Friedman, AH; Bigner, SH
      Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classification

      NEURO-ONCOLOGY
    12. Friedman, HS
      Can O-6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?

      CLINICAL CANCER RESEARCH
    13. Friedman, HS; Kerby, T; Calvert, H
      Temozolomide and treatment of malignant glioma

      CLINICAL CANCER RESEARCH
    14. Middlemas, DS; Stewart, CF; Kirstein, MN; Poquette, C; Friedman, HS; Houghton, PJ; Brent, TP
      Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models

      CLINICAL CANCER RESEARCH
    15. Houghton, PJ; Stewart, CF; Cheshire, PJ; Richmond, LB; Kirstein, MN; Poquette, CA; Tan, M; Friedman, HS; Brent, TP
      Antitumor activity of temozolomide combined with irinotecan is partly independent of O-6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models

      CLINICAL CANCER RESEARCH
    16. Heimberger, AB; Archer, GE; McLendon, RE; Hulette, C; Friedman, AH; Friedman, HS; Bigner, DD; Sampson, JH
      Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats

      CLINICAL CANCER RESEARCH
    17. Patel, VJ; Elion, GB; Houghton, PJ; Keir, S; Pegg, AE; Johnson, SP; Dolan, ME; Bigner, DD; Friedman, HS
      Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft

      CLINICAL CANCER RESEARCH
    18. Mulne, AF; Ducore, JM; Elterman, RD; Friedman, HS; Krischer, JP; Kun, LE; Shuster, JJ; Kadota, RP
      Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group Study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    19. Vaidyanathan, G; Affleck, DJ; Cavazos, CM; Johnson, SP; Shankar, S; Friedman, HS; Colvin, MO; Zalutsky, MR
      Radiolabeled guanine derivatives for the in vivo mapping of O-6-alkylguanine-DNA alkyltransferase: 6-(4-[F-18]fluoro-benzyloxy)-9H-purin-2-ylamine and 6-(3-[I-131]iodo-benzyloxy)-9H-purin-2-ylamine

      BIOCONJUGATE CHEMISTRY
    20. Cokgor, I; Akabani, G; Kuan, CT; Friedman, HS; Friedman, AH; Coleman, RE; McLendon, RE; Bigner, SH; Zhao, XG; Garcia-Turner, AM; Pegram, CN; Wikstrand, CJ; Shafman, TD; Herndon, JE; Provenzale, JM; Zalutsky, MR; Bigner, DD
      Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas

      JOURNAL OF CLINICAL ONCOLOGY
    21. Friedman, HS; Pluda, J; Quinn, JA; Ewesuedo, RB; Long, L; Friedman, AH; Cokgor, I; Colvin, OM; Haglund, MM; Ashley, DM; Rich, JN; Sampson, J; Pegg, AE; Moschel, RC; McLendon, RE; Provenzale, JM; Stewart, ES; Tourt-Uhlig, S; Garcia-Turner, AM; Herndon, JE; Bigner, DD; Dolan, ME
      Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma

      JOURNAL OF CLINICAL ONCOLOGY
    22. Thomas, PRM; Deutsch, M; Kepner, JL; Boyett, JM; Krischer, J; Aronin, P; Albright, L; Allen, JC; Packer, RJ; Linggood, R; Mulhern, R; Stehbens, JA; Langston, J; Stanley, P; Duffner, P; Rorke, L; Cherlow, J; Friedman, HS; Finlay, JL; Vietti, TJ; Kun, LE
      Low-stage medulloblastoma: Final analysis of trial comparing standard-dosewith reduced-dose neuraxis irradiation

      JOURNAL OF CLINICAL ONCOLOGY
    23. Akabani, G; Cokgor, I; Coleman, RE; Trotter, DG; Wong, TZ; Friedman, HS; Friedman, AH; Garcia-Turner, A; Herndon, JE; DeLong, D; McLendon, RE; Zhao, XG; Pegram, CN; Provenzale, JM; Bigner, DD; Zalutsky, MR
      Dosimetry and dose-response relationships in newly diagnosed patients withmalignant gliomas treated with iodine-131-labeled anti-tenascin monoclonalantibody 81C6 therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    24. Friedman, HS; Castellino, RC; Elion, GB; Keir, ST; Houghton, PJ; Johnson, SP; Bigner, DD
      Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (vol 45, pg 345, 1999)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    25. Keir, ST; Dolan, ME; Pegg, AE; Lawless, A; Moschel, RC; Bigner, DD; Friedman, HS
      O-6-benzylguanine-mediated enhancement of nitrosourea activity in Mer(-) central nervous system tumor xenografts - implications for clinical trials

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    26. Friedman, HS; Castellino, RC; Elion, GB; Keir, ST; Houghton, PJ; Johnson, SP; Bigner, DD
      Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    27. Zhou, H; Friedman, HS; von der Heydt, R
      Coding of border ownership in monkey visual cortex

      JOURNAL OF NEUROSCIENCE
    28. Bottom, KS; Ashley, DM; Friedman, HS; Longee, DC
      Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme

      JOURNAL OF NEURO-ONCOLOGY
    29. Friedman, HS; Wattanasuwan, N; Sharafkhaneh, A; Win, M; Mallipeddi, D; Khan, IA; Dai, CP
      The comparative effects of drive and test stimulus intensity on myocardialexcitability and vulnerability

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    30. Lippa, RA; Martin, LR; Friedman, HS
      Gender-related individual differences and mortality in the Terman longitudinal study: Is masculinity hazardous to your health?

      PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN
    31. Friedman, HS
      Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis

      SEMINARS IN ONCOLOGY
    32. von der Heydt, R; Zhou, H; Friedman, HS
      Representation of stereoscopic edges in monkey visual cortex

      VISION RESEARCH
    33. Friedman, HS
      Observational studies and randomized trials.

      NEW ENGLAND JOURNAL OF MEDICINE
    34. Sampson, JH; Crotty, LE; Lee, S; Archer, GE; Ashley, DM; Wikstrandt, CJ; Hale, LP; Small, C; Dranoff, G; Friedman, AH; Friedman, HS; Bigner, DD
      Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Friedman, HS
      Long-term relations of personality and health: Dynamisms, mechanisms, tropisms

      JOURNAL OF PERSONALITY
    36. Martin, LR; Friedman, HS
      Comparing personality scales across time: An illustrative study of validity and consistency in life-span archival data

      JOURNAL OF PERSONALITY
    37. Brown, HG; Kepner, JL; Perlman, EJ; Friedman, HS; Strother, DR; Duffner, PK; Kun, LE; Goldthwaite, PT; Burger, PC
      "Large cell/anaplastic" medulloblastomas: A Pediatric Oncology Group study

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    38. Friedman, HS; Win, M; Hussain, A; Sinha, A
      Effects of cardiac glycosides on atrial contractile dysfunction after short-term atrial fibrillation

      CHEST
    39. Aldosari, N; Rasheed, BKA; McLendon, RE; Friedman, HS; Bigner, DD; Bigner, SH
      Characterization of chromosome 17 abnormalities in medulloblastomas

      ACTA NEUROPATHOLOGICA
    40. Friedman, HS
      Temozolomide - A viewpoint

      CNS DRUGS
    41. Friedman, HS; Rodney, E; Sinha, B; Sharafkhaneh, A; Watanasuwan, N; Win, M; Mallipeddi, D; Sinha, A; Hussain, A; Dai, CP
      Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect

      JOURNAL OF INVESTIGATIVE MEDICINE
    42. Archer, GE; Sampson, JH; Lorimer, IAJ; McLendon, RE; Kuan, CT; Friedman, AH; Friedman, HS; Pastan, IH; Bigner, DD
      Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1

      CLINICAL CANCER RESEARCH
    43. Sampson, JH; Archer, GE; Villavicencio, AT; McLendon, RE; Friedman, AH; Bishop, WR; Bigner, DD; Friedman, HS
      Treatment of neoplastic meningitis with intrathecal temozolomide

      CLINICAL CANCER RESEARCH
    44. Wu, MH; Lohrbach, KE; Olopade, OI; Kokkinakis, DM; Friedman, HS; Dolan, ME
      Lack of evidence for a polymorphism at codon 160 of human O-6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer

      CLINICAL CANCER RESEARCH
    45. Kadota, RP; Kun, LE; Langston, JW; Burger, PC; Cohen, ME; Mahoney, DH; Walter, AW; Rodman, JH; Parent, A; Buckley, E; Kepner, JL; Friedman, HS
      Cyclophosphamide for the treatment of progressive low-grade astrocytoma: Apediatric oncology group phase II study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    46. Tucker, JS; Schwartz, JE; Clark, KM; Friedman, HS
      Age-related changes in the associations of social network ties with mortality risk

      PSYCHOLOGY AND AGING
    47. Cokgor, I; Friedman, HS; Friedman, AH
      Chemotherapy for adults with malignant glioma

      CANCER INVESTIGATION
    48. Yung, WKA; Prados, MD; Yaya-Tur, R; Rosenfeld, SS; Brada, M; Friedman, HS; Albright, R; Olson, J; Chang, SM; O'Neill, AM; Friedman, AH; Bruner, J; Yue, N; Dugan, M; Zaknoen, S; Levin, VA
      Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    49. Friedman, HS; Petros, WP; Friedman, AH; Schaaf, LJ; Kerby, T; Lawyer, J; Parry, M; Houghton, PJ; Lovell, S; Rasheed, K; Cloughsey, T; Stewart, ES; Colvin, OM; Provenzale, JM; McLendon, RE; Bigner, DD; Cokgor, I; Haglund, M; Rich, J; Ashley, D; Malczyn, J; Elfring, GL; Miller, LL
      Irinotecan therapy in adults with recurrent or progressive malignant glioma

      JOURNAL OF CLINICAL ONCOLOGY
    50. Dong, Q; Johnson, SP; Colvin, OM; Bullock, N; Kilborn, C; Runyon, G; Sullivan, DM; Easton, J; Bigner, DD; Nahta, R; Marks, J; Modrich, P; Friedman, HS
      Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    51. Friedman, HS; Pegg, AE; Johnson, SP; Loktionova, NA; Dolan, ME; Modrich, P; Moschel, RC; Struck, R; Brent, TP; Ludeman, S; Bullock, N; Kilborn, C; Keir, S; Dong, Q; Bigner, DD; Colvin, OM
      Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    52. McLendon, RE; Friedman, HS; Fuchs, HE; Kun, LE; Bigner, SH
      Diagnostic markers in paediatric medulloblastoma: Paediatric Oncology Group Study

      HISTOPATHOLOGY
    53. Friedman, HS; Zhou, H; von der Heydt, R
      Color filling-in under steady fixation: Behavioral demonstration in monkeys and humans

      PERCEPTION
    54. Friedman, HS; Riggio, RE
      Individual differences in ability to encode complex affects

      PERSONALITY AND INDIVIDUAL DIFFERENCES
    55. Archer, GE; Sampson, JH; McLendon, RE; Friedman, AH; Colvin, OM; Rose, M; Sands, H; McCullough, W; Fuchs, HE; Bigner, DD; Friedman, HS
      Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats

      JOURNAL OF NEURO-ONCOLOGY
    56. Kadota, RP; Stewart, CF; Horn, M; Kuttesch, JF; Burger, PC; Kepner, JL; Kun, LE; Friedman, HS; Heideman, RL
      Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

      JOURNAL OF NEURO-ONCOLOGY
    57. Friedman, HS; Priebe, CE
      Smoothing bandwidth selection for response latency estimation

      JOURNAL OF NEUROSCIENCE METHODS
    58. Akabani, G; Reist, CJ; Cokgor, I; Friedman, AH; Friedman, HS; Coleman, RE; Zhao, XG; Bigner, DD; Zalutsky, MR
      Dosimetry of I-131-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors

      JOURNAL OF NUCLEAR MEDICINE
    59. Mishra, A; Friedman, HS; Sinha, AK
      The effects of erythromycin on the electrocardiogram

      CHEST
    60. Friedman, HS; Kerby, T; Fields, S; Zilisch, JE; Graden, D; McLendon, RE; Houghton, PJ; Arbuck, S; Cokgor, I; Friedman, AH
      Topotecan treatment of adults with primary malignant glioma

      CANCER
    61. Bigner, SH; Matthews, MR; Rasheed, BKA; Wiltshire, RN; Friedman, HS; Friedman, AH; Stenzel, TT; Dawes, DM; McLendon, RE; Bigner, DD
      Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

      AMERICAN JOURNAL OF PATHOLOGY
    62. LEE SE; JOHNSON SP; HALE LP; LI J; BULLOCK N; FUCHS H; FRIEDMAN A; MCLENDON R; BIGNER DD; MODRICH P; FRIEDMAN HS
      ANALYSIS OF DNA MISMATCH REPAIR PROTEINS IN HUMAN MEDULLOBLASTOMA

      Clinical cancer research
    63. DUFFNER PK; KISCHER JP; SANFORD RA; HOROWITZ ME; BURGER PC; COHEN ME; FRIEDMAN HS; KUN LE
      PROGNOSTIC FACTORS IN INFANTS AND VERY YOUNG-CHILDREN WITH INTRACRANIAL EPENDYMOMAS

      Pediatric neurosurgery
    64. Cokgor, I; Friedman, AH; Friedman, HS
      Paediatric update - Gliomas

      EUROPEAN JOURNAL OF CANCER
    65. Peterson, C; Seligman, MEP; Yurko, KH; Martin, LR; Friedman, HS
      Catastrophizing and untimely death

      PSYCHOLOGICAL SCIENCE
    66. MCLENDON RE; FRIEDMAN HS; BIGNER SH; MODRICH PL
      DNA MISMATCH REPAIR ENZYME DETECTION IN ADULT GLIOBLASTOMA (GBM) BY IMMUNOHISTOCHEMISTRY

      Modern pathology
    67. HOUGHTON PJ; STEWART CF; THOMPSON J; SANTANA VM; FURMAN WL; FRIEDMAN HS
      PRECLINICAL AND CLINICAL-RESULTS WITH IRINOTECAN - EXTENDING PRINCIPLES LEARNED IN MODEL SYSTEMS TO CLINICAL-TRIALS DESIGN

      Oncology
    68. BIGNER DD; BROWN MT; FRIEDMAN AH; COLEMAN RE; AKABANI G; FRIEDMAN HS; THORSTAD WL; MCLENDON RE; BIGNER SH; ZHAO XG; PEGRAM CN; WIKSTRAND CJ; HERNDON JE; VICK NA; PALEOLOGOS N; COKGOR I; PROVENZALE JM; ZALUTSKY MR
      IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS

      Journal of clinical oncology
    69. MULHERN RK; KEPNER JL; THOMAS PR; ARMSTRONG FD; FRIEDMAN HS; KUN LE
      NEUROPSYCHOLOGIC FUNCTIONING OF SURVIVORS OF CHILDHOOD MEDULLOBLASTOMA RANDOMIZED TO RECEIVE CONVENTIONAL OR REDUCED-DOSE CRANIOSPINAL IRRADIATION - A PEDIATRIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    70. FRIEDMAN HS; KOKKINAKIS DM; PLUDA J; FRIEDMAN AH; COKGOR I; HAGLUND MM; ASHLEY DM; RICH J; DOLAN ME; PEGG AE; MOSCHEL RC; MCLENDON RE; KERBY T; HERNDON JE; BIGNER DD; SCHOLD SC
      PHASE-I TRIAL OF O-6-BENZYLGUANINE FOR PATIENTS UNDERGOING SURGERY FOR MALIGNANT GLIOMA

      Journal of clinical oncology
    71. Friedman, HS; McLendon, RE; Kerby, T; Dugan, M; Bigner, SH; Henry, AJ; Ashley, DM; Krischer, J; Lovell, S; Rasheed, K; Marchev, F; Seman, AJ; Cokgor, I; Rich, J; Stewart, E; Colvin, OM; Provenzale, JM; Bigner, DD; Haglund, MM; Friedman, AH; Modrich, PL
      DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma

      JOURNAL OF CLINICAL ONCOLOGY
    72. DUFFNER PK; KRISCHER JP; HOROWITZ ME; COHEN ME; BURGER PC; FRIEDMAN HS; KUN LE
      2ND MALIGNANCIES IN YOUNG-CHILDREN WITH PRIMARY BRAIN-TUMORS FOLLOWING TREATMENT WITH PROLONGED POSTOPERATIVE CHEMOTHERAPY AND DELAYED IRRADIATION - A PEDIATRIC-ONCOLOGY-GROUP STUDY

      Annals of neurology
    73. HANLEY ML; ELION GB; COLVIN OM; MODRICH PL; KEIR S; ADAMS DJ; BIGNER DD; FRIEDMAN HS
      THERAPEUTIC EFFICACY OF VINORELBINE AGAINST PEDIATRIC AND ADULT CENTRAL-NERVOUS-SYSTEM TUMORS

      Cancer chemotherapy and pharmacology
    74. COGGINS CA; ELION GB; HOUGHTON PJ; HARE CB; KEIR S; COLVIN OM; BIGNER DD; FRIEDMAN HS
      ENHANCEMENT OF IRINOTECAN (CPT-11) ACTIVITY AGAINST CENTRAL-NERVOUS-SYSTEM TUMOR XENOGRAFTS BY ALKYLATING-AGENTS

      Cancer chemotherapy and pharmacology
    75. FRIEDMAN HS; PRIEBE CE
      ESTIMATING STIMULUS-RESPONSE LATENCY

      Journal of neuroscience methods
    76. VALDYANATHAN G; FRIEDMAN HS; ZALUTSKY MR
      N.C.A. -1(2-DEOXY,2-FLUORO-BETA-D-ARABINOFURANOSYL)URACIL (FIAU) - TISSUE UPTAKE IN D-54 GLIOMA XENOGRAFT MOUSE MODEL AND CYTOTOXICITY TO D-247 GLIOMA-CELLS IN-VITRO

      The Journal of nuclear medicine
    77. BURGER PC; YU IT; TIHAN T; FRIEDMAN HS; STROTHER DR; KEPNER JL; DUFFNER PK; KUN LE; PERLMAN EJ
      ATYPICAL TERATOID RHABDOID TUMOR OF THE CENTRAL-NERVOUS-SYSTEM - A HIGHLY MALIGNANT-TUMOR OF INFANCY AND CHILDHOOD FREQUENTLY MISTAKEN FOR MEDULLOBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY/

      The American journal of surgical pathology
    78. FRIEDMAN HS; LOVELL S; RASHEED K; FRIEDMAN AH
      TREATMENT OF ADULTS WITH PROGRESSIVE OLIGODENDROGLIOMA WITH CARBOPLATIN (CBDCA) - PRELIMINARY-RESULTS

      Medical and pediatric oncology
    79. MCCOWAGE GB; FRIEDMAN HS; MOGHRABI A; KERBY T; FERRELL L; STEWART E; DUNCANBROWN M; FUCHS HE; TIEN R; MCLENDON RE; MEIER L; KURTZBERG J; ASHLEY D; COLVIN OM; LONGEE DC
      ACTIVITY OF HIGH-DOSE CYCLOPHOSPHAMIDE IN THE TREATMENT OF CHILDHOOD MALIGNANT GLIOMAS

      Medical and pediatric oncology
    80. PROVENZALE JM; SAKURAI M; BOTTOM KS; KLINTWORTH GK; BUCKLEY EG; FRIEDMAN HS
      PATTERNS OF CNS INVOLVEMENT AND CLINICAL OUTCOME IN TRILATERAL RETINOBLASTOMA

      Radiology
    81. PROVENZALE JM; RODRIGUEZ D; COLEMAN RE; FRIEDMAN HS; AKABANI G; COKGOR I
      WORSENING MR AND PET FINDINGS DO NOT NECESSARILY INDICATE TUMOR PROGRESSION IN PATIENTS WITH RESECTED PRIMARY BRAIN-TUMORS UNDERGOING TREATMENT WITH INTRACAVITARY IODINE-131-LABELED ANTI-TENASCIN MONOCLONAL-ANTIBODY

      Radiology
    82. COKGOR I; AKABANI G; BROWN MT; FRIEDMAN AH; COLEMAN RE; FRIEDMAN HS; THORSTAD WL; MCLENDON RE; BIGNER SH; ZHAO XG; PEGRAM CN; WIKSTRAND CJ; HERNDON JE; VICK NA; PALEOLOGOS N; ZALUTSKY MR; BIGNER DD
      RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES

      Neurology
    83. MCLENDON RE; CLEVELAND L; PEGRAM C; BIGNER SH; BIGNER DD; FRIEDMAN HS
      IMMUNOHISTOCHEMICAL DETECTION OF THE DNA-REPAIR ENZYME O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN FORMALIN-FIXED, PARAFFIN-EMBEDDED ASTROCYTOMAS

      Laboratory investigation
    84. GRAHAM ML; HERNDON JE; CASEY JR; CHAFFEE S; CIOCCI GH; KRISCHER JP; KURTZBERG J; LAUGHLIN MJ; LONGEE DC; OLSON JF; PALEOLOGUS N; PENNINGTON CN; FRIEDMAN HS
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH RECURRENT AND HIGH-RISK PEDIATRIC BRAIN-TUMORS

      Journal of clinical oncology
    85. ASHLEY DM; COLEMAN RE; FUCHS H; DEAR G; GINSBERG B; ZALDUONDO FM; FRIEDMAN HS; LONGEE D
      CHRONIC CSF LEAK INTO THE PERITONEAL-CAVITY SHOWN BY RADIONUCLIDE CISTERNOGRAPHY - SUCCESSFUL TREATMENT WITH AN EPIDURAL BLOOD PATCH

      Clinical nuclear medicine
    86. HARE CB; ELION GB; COLVIN OM; ALIOSMAN F; GRIFFITH OW; PETROS WP; KEIR S; MARCELLI SL; BIGNER DD; FRIEDMAN HS
      CHARACTERIZATION OF THE MECHANISMS OF BUSULFAN RESISTANCE IN A HUMAN GLIOBLASTOMA-MULTIFORME XENOGRAFT

      Cancer chemotherapy and pharmacology
    87. KURPAD SN; DOLAN ME; MCLENDON RE; ARCHER GE; MOSCHEL RC; PEGG AE; BIGNER DD; FRIEDMAN HS
      INTRAARTERIAL O-6-BENZYLGUANINE ENABLES THE SPECIFIC THERAPY OF NITROSOUREA-RESISTANT INTRACRANIAL HUMAN GLIOMA XENOGRAFTS IN ATHYMIC RATS WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA

      Cancer chemotherapy and pharmacology
    88. MOYNIHAN K; ELION GB; PEGRAM C; REIST CJ; WELLNER D; BIGNER DD; GRIFFITH OW; FRIEDMAN HS
      L-AMINO-ACID OXIDASE (LOX) MODULATION OF MELPHALAN ACTIVITY AGAINST INTRACRANIAL GLIOMA

      Cancer chemotherapy and pharmacology
    89. HARE CB; ELION GB; HOUGHTON PJ; HOUGHTON JA; MARCELLI SL; KEIR S; BIGNER DD; FRIEDMAN HS
      THERAPEUTIC EFFICACY OF THE TOPOISOMERASE-I INHIBITOR PIPERIDINO]-1-PIPERIDINO)-CARBONYLOXY-CAMPTOTHECIN AGAINST PEDIATRIC AND ADULT CENTRAL-NERVOUS-SYSTEM TUMOR XENOGRAFTS

      Cancer chemotherapy and pharmacology
    90. BIGNER SH; MCLENDON RE; FUCHS H; MCKEEVER PE; FRIEDMAN HS
      CHROMOSOMAL CHARACTERISTICS OF CHILDHOOD BRAIN-TUMORS

      Cancer genetics and cytogenetics
    91. VONDERHEYDT R; FRIEDMAN HS; ZHOU H; KOMATSU H; HANAZAWA A; MURAKAMI I
      NEURONAL RESPONSES IN MONKEY V1 AND V2 UNAFFECTED BY METACONTRAST

      Investigative ophthalmology & visual science
    92. FRIEDMAN HS
      EFFECTIVENESS OF RIGHT HEART CATHETERIZATION - TIME FOR A RANDOMIZED TRIAL

      JAMA, the journal of the American Medical Association
    93. MOGHRABI A; TIEN R; FUCHS H; LONGEE D; MCLENDON R; FRIEDMAN HS
      FALSE-POSITIVE IMAGES IN THE FOLLOW-UP OF PATIENTS WITH BRAIN-TUMORS

      Medical and pediatric oncology
    94. TUCKER JS; FRIEDMAN HS; SCHWARTZ JE; CRIQUI MH; TOMLINSONKEASEY C; WINGARD DL; MARTIN LR
      PARENTAL DIVORCE - EFFECTS ON INDIVIDUAL BEHAVIOR AND LONGEVITY

      Journal of personality and social psychology
    95. KUPCZYKSUBOTKOWSKA L; SIAHAAN TJ; BASILE AS; FRIEDMAN HS; HIGGINS PE; SONG D; GALLO JM
      MODULATION OF MELPHALAN RESISTANCE IN GLIOMA-CELLS WITH A PERIPHERAL BENZODIAZEPINE RECEPTOR-LIGAND MELPHALAN CONJUGATE

      Journal of medicinal chemistry
    96. STENZEL TT; RASHEED BKA; MCLENDON RE; PARSONS R; FRIEDMAN AH; FRIEDMAN HS; BIGNER SH
      PTEN GENE-MUTATIONS ARE SEEN IN HIGH-GRADE, BUT NOT IN LOW-GRADE GLIOMAS

      Clinical chemistry
    97. FRIEDMAN HS
      METHYLATOR RESISTANCE MEDIATED BY MISMATCH REPAIR DEFICIENCY IN A GLIOBLASTOMA MULTI FORME XENOGRAFT (VOL 57, PG 2933, 1997)

      Cancer research
    98. RASHEED BKA; STENZEL TT; MCLENDON RE; PARSONS R; FRIEDMAN AH; FRIEDMAN HS; BIGNER DD; BIGNER SH
      PTEN GENE-MUTATIONS ARE SEEN IN HIGH-GRADE BUT NOT IN LOW-GRADE GLIOMAS

      Cancer research
    99. FRIEDMAN HS; JOHNSON SP; DONG Q; SCHOLD SC; RASHEED BKA; BIGNER SH; ALIOSMAN F; DOLAN E; COLVIN OM; HOUGHTON P; GERMAIN G; DRUMMOND JT; KEIR S; MARCELLI S; BIGNER DD; MODRICH P
      METHYLATOR RESISTANCE MEDIATED BY MISMATCH REPAIR DEFICIENCY IN A GLIOBLASTOMA-MULTIFORME XENOGRAFT

      Cancer research
    100. MCLENDON RE; BENTLEY RC; PARISI JE; TIEN RD; HARRISON JC; TARBELL NJ; BILLITT AL; GUALTIERI RJ; FRIEDMAN HS
      MALIGNANT SUPRATENTORIAL GLIAL-NEURONAL NEOPLASMS - REPORT OF 2 CASESAND REVIEW OF THE LITERATURE

      Archives of pathology and laboratory medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 23:28:58